{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T22:58:44Z","timestamp":1770505124441,"version":"3.49.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1996,3,1]],"date-time":"1996-03-01T00:00:00Z","timestamp":825638400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Digest Dis Sci"],"published-print":{"date-parts":[[1996,3]]},"DOI":"10.1007\/bf02282317","type":"journal-article","created":{"date-parts":[[2006,1,25]],"date-time":"2006-01-25T14:00:24Z","timestamp":1138197624000},"page":"453-457","source":"Crossref","is-referenced-by-count":14,"title":["Dual therapy versus triple therapy forHelicobacter pylori-associated duodenal ulcers"],"prefix":"10.1007","volume":"41","author":[{"given":"Joseph J. Y.","family":"Sung","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. C.","family":"Sydney Chung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas K. W.","family":"Ling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roamy","family":"Suen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent K. S.","family":"Leung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James Y. W.","family":"Lau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Augustine F. B.","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arthur K. C.","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02282317_CR1","doi-asserted-by":"crossref","first-page":"770","DOI":"10.7326\/0003-4819-116-9-770","volume":"116","author":"JH Walsh","year":"1992","unstructured":"Walsh JH:Helicobacter pylori: Selection of patients for treatment. Ann Intern Med 116:770\u2013771, 1992","journal-title":"Ann Intern Med"},{"key":"BF02282317_CR2","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/jama.1994.03520010077036","volume":"272","author":"NIH Consensus Conference","year":"1994","unstructured":"NIH Consensus Conference:Helicobacter pylori in peptic ulcer disease. NIH Consensus Development Panel onHelicobacter pylori in peptic ulcer disease. JAMA 272:65\u201369, 1994","journal-title":"JAMA"},{"key":"BF02282317_CR3","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/S0140-6736(94)91460-5","volume":"343","author":"SW Hosking","year":"1994","unstructured":"Hosking SW, Ling TKW, Chung SCS, Yung MY, Cheng AFB, Sung JY, Li AKC: EradicatingHelicobacter pylori heals duodenal ulcers without anti-secretory therapy: A randomized controlled trial. Lancet 343:508\u2013510, 1994","journal-title":"Lancet"},{"key":"BF02282317_CR4","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1056\/NEJM199501193320302","volume":"332","author":"JY Sung","year":"1995","unstructured":"Sung JY, Chung SCS, Ling TKW, Yung MY, Leung VKS, Ng EKW, Li MKK, Cheng AFB, Li AKC: Antibacterial treatment of gastric ulcers associated withHelicobacter pylori. N Engl J Med 332:139\u2013142, 1995","journal-title":"N Engl J Med"},{"key":"BF02282317_CR5","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/0016-5085(92)90095-G","volume":"102","author":"DY Graham","year":"1992","unstructured":"Graham DY, Lew GM, Malaty HM, Evans DG, Evans DJ, Klein PD, Alpert LC, Genta RM: Factors influencing the eradication ofHelicobacter pylori with triple therapy. Gastroenterology 102;493\u2013496, 1992","journal-title":"Gastroenterology"},{"key":"BF02282317_CR6","first-page":"923","volume":"3","author":"GD Bell","year":"1991","unstructured":"Bell GD, Powell K, Weil J, et al: Experience with omeprazole in combination with either amoxicillin or colloidal bismuth subcitrate in patients with metronidazole-resistantHelicobacter pylori. Eur J Gastroenterol Hepatol 3:923\u2013926, 1991","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"BF02282317_CR7","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/00042737-199305000-00005","volume":"5","author":"P Unge","year":"1993","unstructured":"Unge P, Gad A, Eriksson K, et al: Amoxicillin added to omeprazole prevents relapse in the treatment of duodenal ulcer patient. Eur J Gastroenterol Hepatol 5:325\u2013331, 1993","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"BF02282317_CR8","first-page":"697","volume":"4","author":"E Bayerdorfer","year":"1992","unstructured":"Bayerdorfer E, Mannes GA, Sommer A, et al: High dose omeprazole treatment combined with amoxicillin eradicatesHelicobacter pylori. Eur J Gastroenterol Hepatol 4:697\u2013702, 1992","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"BF02282317_CR9","unstructured":"Mohamed H, Chiba N, Wilkinson J, Hunt R: Eradication ofHelicobacter pylori: A meta-analysis. Gastroenterology 106:A142, 1994"},{"key":"BF02282317_CR10","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1136\/gut.34.9.1167","volume":"34","author":"J Labenz","year":"1993","unstructured":"Labenz J, Gyenes E, Ruhl GH, et al: Amoxicillin plus omeprazole versus triple therapy for eradication ofHelicobacter pylori in duodenal ulcer disease: A prospective, randomized and controlled study. Gut 34:1167\u20131170, 1993","journal-title":"Gut"},{"key":"BF02282317_CR11","doi-asserted-by":"crossref","first-page":"934","DOI":"10.3109\/00365529309098287","volume":"28","author":"JC Thys","year":"1993","unstructured":"Thys JC, van Zwet AA, Oey HB: Efficacy and side effects of a triple drug regimen for the eradication ofH. pylori. Scand J Gastroenterol 28:934\u2013938, 1993","journal-title":"Scand J Gastroenterol"},{"key":"BF02282317_CR12","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1365-2036.1992.tb00556.x","volume":"6","author":"GD Bell","year":"1992","unstructured":"Bell GD, Powell K, Burridge SM, et al: Experience with triple anti-H. pylori eradication therapy: Side effects and the importance of testing the pre-treatment bacterial isolate for metronidazole resistance. Aliment Pharmacol Ther 6:427\u2013435, 1992","journal-title":"Aliment Pharmacol Ther"},{"key":"BF02282317_CR13","first-page":"481","volume":"4","author":"JA Louw","year":"1992","unstructured":"Louw JA, Zak J, Jaskiewicz K, et al: Omeprazole may clear but does not eradicateH. pylori. Eur J Gastroenterol Hepatol 4:481\u2013485, 1992","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"BF02282317_CR14","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0140-6736(95)92962-2","volume":"345","author":"W Boer de","year":"1995","unstructured":"de Boer W, Driessen W, Jansz A, et al: Effect of acid suppression on efficacy of treatment forHelicobacter pylori infection. Lancet 345:817\u2013820, 1995","journal-title":"Lancet"},{"key":"BF02282317_CR15","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/BF01300082","volume":"36","author":"TU Westblom","year":"1991","unstructured":"Westblom TU, Duriex DE: Enhancement of antibiotic concentrations in gastric mucosa by H2RA-implications for treatment ofH. pylori infection. Dig Dis Sci 36:25\u201328, 1991","journal-title":"Dig Dis Sci"},{"key":"BF02282317_CR16","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1093\/jac\/22.5.729","volume":"22","author":"CAM McNulty","year":"1988","unstructured":"McNulty CAM, Dent JC, Ford GA, Wilkinson SP: Inhibitory antimicrobial concentrations againstH. pylori in gastric mucosa. J Antimicrob Chemother 22:729\u2013738, 1988","journal-title":"J Antimicrob Chemother"},{"key":"BF02282317_CR17","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.3109\/00365529409094890","volume":"29","author":"J Labenz","year":"1994","unstructured":"Labenz J, Leverkus F, Borsch G: Omeprazole plus amoxicillin for cure ofH. pylori infection: Factors influencing the treatment success. Scand J Gastroenterol 29:1070\u20131075, 1994","journal-title":"Scand J Gastroenterol"},{"key":"BF02282317_CR18","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1136\/gut.36.1.12","volume":"36","author":"RP Logan","year":"1995","unstructured":"Logan RP, Walker MM, Misiewicz JJ, Gummett PA, Karim QN, Baron JH: Changes in the intragastric distribution ofHelicobacter pylori during treatment with omeprazole. Gut 36:12\u201316, 1995","journal-title":"Gut"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02282317.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02282317\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02282317","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,15]],"date-time":"2019-05-15T18:44:01Z","timestamp":1557945841000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02282317"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,3]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1996,3]]}},"alternative-id":["BF02282317"],"URL":"https:\/\/doi.org\/10.1007\/bf02282317","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[1996,3]]}}}